Insider filing · RNTX

Voss Capital, LP bought $375K of Rein Therapeutics (RNTX)

Executed Oct 27 2025, disclosed Oct 28 2025, 1 day later.

Over the 21 trading sessions from the disclosed entry session (Oct 28 2025), the stock returned +5.8% (delay-adjusted); from the execution session (Oct 27 2025), +0.7%. Derived: entry at the session's open, exit at the close 20 sessions later.

VL Voss Capital, LP 10% owner profile →

Voss Capital, LP (10% owner) filed 12 Form 4 reports as a reporting entity in the trailing twelve months (9 purchases, 3 sales, 3 filed past the two-business-day deadline), most often in Flywire Corporation (FLYW). Across 9 priced purchase filings, the average 21-session return was +3.4% from execution and -3.6% from disclosure (delay-adjusted; derived). The largest single filing was $14.6M of PAR (524,064 sh across 9 lots, as filed), executed Jan 14.

RNTX RNTX RNTX · 2 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→